Featured Articles

Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a deal valued at $1.65 billion, bringing together two companies with expertise in radiopharmaceutical…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Bayer’s HYRNUO (sevabertinib) as a first-line treatment for adults with locally advanced or metastatic…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Ionis Pharmaceuticals’ ZANVASTRO™ (zilganersen) for the treatment of Alexander disease (AxD) in pediatric and adult patients.…
Read More...

GSK has reported positive Phase II results for its mRNA seasonal influenza vaccine candidate, with the company planning to begin a Phase III efficacy trial in September 2026. The…
Read More...

Novartis has reported positive topline results from its Phase III REMODEL-1 and REMODEL-2 trials evaluating remibrutinib in adults with relapsing multiple sclerosis (RMS). The oral…
Read More...

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced a shared commitment with the Trump Administration to explore ways to lower the cost of…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at…
Read More...

The U.S. Food and Drug Administration (FDA) has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 infection in children weighing at least 2 kg. The…
Read More...

The U.S. Food and Drug Administration (FDA) has approved two Ziihera (zanidatamab-hrii)-based treatment regimens for the first-line treatment of adults with unresectable locally…
Read More...

Lundbeck has received orphan designation from the European Commission for asedebart (Lu AG13909), an experimental monoclonal antibody being developed to treat Cushing’s syndrome of…
Read More...

Takeda has received approval in Japan for ORZEYFUL (oveporexton), a new oral treatment for adults with narcolepsy type 1 (NT1), a rare neurological disorder that causes excessive…
Read More...

GSK has received approval in Japan for Hibsago (bepirovirsen), an antisense oligonucleotide (ASO) treatment designed to provide a functional cure for chronic hepatitis B (CHB) in…
Read More...

Charles River Laboratories and Medigen Vaccine Biologics have entered into a collaboration to support the development of Medigen’s next-generation multivalent enterovirus vaccine.…
Read More...

Regeneron Pharmaceuticals has received U.S. Food and Drug Administration approval for Pasatru (garetosmab-grts), a new treatment for adults living with fibrodysplasia ossificans…
Read More...

LEO Pharma has agreed to acquire worldwide rights to dersimelagon from Tanabe Pharma in a deal that could reach up to $435 million in upfront and near-term milestone payments.…
Read More...

The European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for Pfizer and Valneva’s investigational Lyme disease vaccine, allowing the regulatory…
Read More...

Eli Lilly and Company has filed six new lawsuits against U.S. entities accused of selling unauthorized retatrutide products, escalating the pharmaceutical company's efforts to combat…
Read More...

Swedish pharmaceutical company Sobi and Innate Pharma have entered into a strategic partnership to advance lacutamab, an investigational treatment for cutaneous T-cell lymphoma (CTCL),…
Read More...

Pfizer has reported positive topline results from two Phase 3 trials evaluating LITFULO (ritlecitinib) in patients with nonsegmental vitiligo (NSV), supporting the company’s plans to…
Read More...

AbCellera and Vertex Pharmaceuticals have entered into a collaboration to research, develop, manufacture and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases…
Read More...